<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
<headerData>
<submissionType>144</submissionType>
<filerInfo>
<filer>
<filerCredentials>
<cik>0001468223</cik>
<ccc>XXXXXXXX</ccc>
</filerCredentials>
</filer>
<liveTestFlag>LIVE</liveTestFlag>



</filerInfo>
</headerData>
<formData>
<issuerInfo>
<issuerCik>0001819133</issuerCik>
<issuerName>Tango Therapeutics, Inc.</issuerName>
<secFileNumber>001-39485</secFileNumber>
<issuerAddress>
<com:street1>201 Brookline Ave</com:street1>
<com:street2>Suite 901</com:street2>
<com:city>Boston</com:city>
<com:stateOrCountry>MA</com:stateOrCountry>
<com:zipCode>02215</com:zipCode>
</issuerAddress>
<issuerContactPhone>857-320-4900</issuerContactPhone>
<nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>MVA Investors, LLC</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
<relationshipsToIssuer>
<relationshipToIssuer>member of group owning over 10% of the shares</relationshipToIssuer>
</relationshipsToIssuer>
</issuerInfo>
<securitiesInformation>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<brokerOrMarketmakerDetails>
<name>BofA Securities Inc.</name>
<address>
<com:street1>1111 Ave of the Americas</com:street1>
<com:street2>One Bryant Park</com:street2>
<com:city>New York</com:city>
<com:stateOrCountry>NY</com:stateOrCountry>
<com:zipCode>10036-6706</com:zipCode>
</address>
</brokerOrMarketmakerDetails>
<noOfUnitsSold>75000</noOfUnitsSold>
<aggregateMarketValue>577500</aggregateMarketValue>
<noOfUnitsOutstanding>106718315</noOfUnitsOutstanding>
<approxSaleDate>05/01/2024</approxSaleDate>
<securitiesExchangeName>Nasdaq</securitiesExchangeName>
</securitiesInformation>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>04/07/2020</acquiredDate>
<natureOfAcquisitionTransaction>Private Financing</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Tango Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>21082</amountOfSecuritiesAcquired>
<paymentDate>04/07/2020</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>03/11/2021</acquiredDate>
<natureOfAcquisitionTransaction>Private Financing</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Tango Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>30442</amountOfSecuritiesAcquired>
<paymentDate>03/11/2021</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<securitiesToBeSold>
<securitiesClassTitle>Common Stock</securitiesClassTitle>
<acquiredDate>10/12/2022</acquiredDate>
<natureOfAcquisitionTransaction>Open Market Purchases</natureOfAcquisitionTransaction>
<nameOfPersonfromWhomAcquired>Tango Therapeutics, Inc.</nameOfPersonfromWhomAcquired>
<isGiftTransaction>N</isGiftTransaction>
<amountOfSecuritiesAcquired>23476</amountOfSecuritiesAcquired>
<paymentDate>10/12/2022</paymentDate>
<natureOfPayment>Cash</natureOfPayment>
</securitiesToBeSold>
<nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
<remarks>Aggregate Market Value as of 4/30/2024.</remarks>
<noticeSignature>
<noticeDate>05/01/2024</noticeDate>
<signature>/s/ Aaron Davis, Chief Executive Officer</signature>
</noticeSignature>
</formData>
</edgarSubmission>
